An Unvaccinated Tetanus Case Discharged without Sequelae
    PDF
    Cite
    Share
    Request
    Case Report
    P: 136-139
    December 2020

    An Unvaccinated Tetanus Case Discharged without Sequelae

    J Pediatr Emerg Intensive Care Med 2020;7(3):136-139
    1. Ankara Şehir Hastanesi, Çocuk Hastanesi, Çocuk Yoğun Bakım Kliniği, Ankara, Türkiye
    2. Ankara Şehir Hastanesi, Çocuk Hastanesi, Çocuk Enfeksiyon Kliniği, Ankara, Türkiye
    No information available.
    No information available
    Received Date: 09.09.2019
    Accepted Date: 06.12.2019
    Publish Date: 18.12.2020
    PDF
    Cite
    Share
    Request

    ABSTRACT

    Tetanus is an acute-onset disease that results from exposure to the exotoxins produced by Clostridium tetani. It is characterized by tonic muscle spasms and has high morbidity and mortality. Respiratory failure is the most severe problem related to generalized tetanus. Mechanical ventilation is almost always mandatory for the therapy of respiratory insufficiency in patients with tetanus-developed airway obstruction. The patient presented herein was 15 years old and unvaccinated, and had generalized tetanus and respiratory failure. He was transported to pediatric intensive care unit following intubation. In this report, we aimed to present the follow-up and treatment of a patient with severe tetanus in pediatric intensive care unit.

    Keywords: Tetanus, pediatric intensive care, immunization

    References

    1
    Wen SC, Webb C, Miles F, Wilson EJ. Tetanus in New Zealand children: Intensive care management of a vaccine preventable disease. Paediatr Child Health. 2016;52:1070-4.
    2
    Salman C, Sekban N, Döşemeci L, Cengiz M, Yılmaz M, et al. Tetanus in our intensive care unit: Evaluation of treatment, complications and mortality in 17 patients. Turk J Anaesthesiol Reanim. 2007;35:200-8.
    3
    Demir NA, Sumer S, Ural O, Ozturk S, Celik BJ. An alternative treatment approach in tetanus: Botulinum toxin. Tropical Doctor. 2015;45:46-8.
    4
    Edlich RF, Hill LG, Mahler CA, Cox MJ, Becker DG, et al. Management and prevention of tetanus. J Long Term Eff Med Implants. 2003;13:139-54.
    5
    The Pink Book: Course Textbook. Epidemiology and Prevention of Vaccine-Preventable Diseases. Chapter 21,Tetanus. 13th edition Atlanta Georgia: Centers for Disease Control and Prevention;2015:342-52. Available from: https: //www.cdc.gov/vaccines/pubs/pinkbook/tetanus.html
    6
    Ergonul O, Egeli D, Kahyaoglu B, Bahar M, Etienne M, et al. An unexpected tetanus case. Lancet Infect Dis. 2016;16:746-52.
    7
    Koruk St, Söğüt Ö, Karaağaç L, Çalışır C, Yalçın Ş. Unforgettable disease: A very rapid tetanus case. JAEM. 2013;12:174-7.
    8
    Hassel B. Tetanus: pathophysiology, treatment, and the possibility of using botulinum toxin against tetanus-ınduced rigidity and spasms. Toxins (Basel). 2013;5:73-83.
    9
    Cook TM, Protheroe RT, Handel JM. Tetanus: a review of the literature. Br J Anaesth. 2001;87:477-87.
    10
    Gregorakos L, Kerezoudi E, Dimopoulos G, Thomaides T. Management of blood pressure instability in severe tetanus: the use of clonidine. Intensive Care Med. 1997;23:893-95.
    11
    Attygalle D, Rodrigo N. Magnesium as first line therapy in the management of tetanus: A prospevtive study of 40 patients. Anaesthesia. 2002;57:811-7.
    12
    Freshwater-Turner D, Udy A, Limpsn J, Deans R, Stuart J, et al. Autonomic dysfunction in tetanus- what lessons can be learnt with specific reference to alpha-2 agonists? Anaesthesia. 2007;62:1066-70.
    13
    Sun C, Zhao H, Wang Z, Xue W, Lu S, et al. Prognostic factors for generalized tetanus in adults: A retrospective study in a Chinese hospital. Am J Emerg Med. 2019;37:254-9.
    14
    Girgin NK, Iscimen R, Gurbet A, Kahveci F, Kutlay O. Dexmedetomidine sedation for the treatment of tetanus in the intensive care unit. Br J Anaesth. 2007;99:599-600.
    15
    Ozer-Cınar S, Isıl CT, Paksoy I. Dexmedetomidine in the management of severe tetanus. Indıan J Anaesth. 2014;58:96-7.
    2024 ©️ Galenos Publishing House